Form 8-K - Current report:
SEC Accession No. 0001104659-24-104667
Filing Date
2024-10-01
Accepted
2024-10-01 08:00:27
Documents
43
Period of Report
2024-10-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425286d1_8k.htm   iXBRL 8-K 25917
2 EXHIBIT 99.1 tm2425286d1_ex99-1.htm EX-99.1 39603
6 GRAPHIC tm2425286d1_ex99-1img001.jpg GRAPHIC 48229
7 GRAPHIC tm2425286d1_ex99-1img002.jpg GRAPHIC 206510
8 GRAPHIC tm2425286d1_ex99-1img003.jpg GRAPHIC 93455
9 GRAPHIC tm2425286d1_ex99-1img004.jpg GRAPHIC 117743
10 GRAPHIC tm2425286d1_ex99-1img005.jpg GRAPHIC 79448
11 GRAPHIC tm2425286d1_ex99-1img006.jpg GRAPHIC 124401
12 GRAPHIC tm2425286d1_ex99-1img007.jpg GRAPHIC 131374
13 GRAPHIC tm2425286d1_ex99-1img008.jpg GRAPHIC 129751
14 GRAPHIC tm2425286d1_ex99-1img009.jpg GRAPHIC 51327
15 GRAPHIC tm2425286d1_ex99-1img010.jpg GRAPHIC 128871
16 GRAPHIC tm2425286d1_ex99-1img011.jpg GRAPHIC 95093
17 GRAPHIC tm2425286d1_ex99-1img012.jpg GRAPHIC 122131
18 GRAPHIC tm2425286d1_ex99-1img013.jpg GRAPHIC 150764
19 GRAPHIC tm2425286d1_ex99-1img014.jpg GRAPHIC 109486
20 GRAPHIC tm2425286d1_ex99-1img015.jpg GRAPHIC 163120
21 GRAPHIC tm2425286d1_ex99-1img016.jpg GRAPHIC 113379
22 GRAPHIC tm2425286d1_ex99-1img017.jpg GRAPHIC 129320
23 GRAPHIC tm2425286d1_ex99-1img018.jpg GRAPHIC 139178
24 GRAPHIC tm2425286d1_ex99-1img019.jpg GRAPHIC 57834
25 GRAPHIC tm2425286d1_ex99-1img020.jpg GRAPHIC 83663
26 GRAPHIC tm2425286d1_ex99-1img021.jpg GRAPHIC 109161
27 GRAPHIC tm2425286d1_ex99-1img022.jpg GRAPHIC 127576
28 GRAPHIC tm2425286d1_ex99-1img023.jpg GRAPHIC 104029
29 GRAPHIC tm2425286d1_ex99-1img024.jpg GRAPHIC 55918
30 GRAPHIC tm2425286d1_ex99-1img025.jpg GRAPHIC 92699
31 GRAPHIC tm2425286d1_ex99-1img026.jpg GRAPHIC 178185
32 GRAPHIC tm2425286d1_ex99-1img027.jpg GRAPHIC 122818
33 GRAPHIC tm2425286d1_ex99-1img028.jpg GRAPHIC 129833
34 GRAPHIC tm2425286d1_ex99-1img029.jpg GRAPHIC 56088
  Complete submission text file 0001104659-24-104667.txt   4653734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcli-20241001.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20241001_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20241001_pre.xml EX-101.PRE 22373
45 EXTRACTED XBRL INSTANCE DOCUMENT tm2425286d1_8k_htm.xml XML 3691
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 241341364
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)